• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[3H] -双链DNA/抗DNA免疫复合物形成、红细胞结合及释放至血清中的动力学:DNA分子量及抗体过量条件的影响

The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.

作者信息

Horgan C, Burge J, Crawford L, Taylor R P

出版信息

J Immunol. 1984 Oct;133(4):2079-84.

PMID:6332147
Abstract

[3H]dsDNA/anti-DNA immune complexes (IC) formed, fixed complement, and bound rapidly to red blood cells (RBC) in whole blood (less than 5 min), but were released from the cells more slowly. The rate of release was dependent on both the antibody:DNA ratio and the m.w. of the DNA in the complex. For example, complexes formed with high m.w. DNA (6 X 10(6) daltons) were released more slowly (t1/2 = 60 min) than complexes formed with lower m.w. DNA (2 to 6 X 10(5) daltons, t1/2 = 15 to 20 min). The [3H]dsDNA/anti-DNA complexes, which were released from the cells as intact antigen/antibody/complement complexes, did not rebind to RBC, but did bind to Raji cells and could be precipitated by monoclonal antibody to C3d. When these released IC (RIC) containing high m.w. DNA were incubated with additional anti-DNA antibody and fresh complement, they rebound to RBC. However, RIC containing lower m.w. DNA (5 X 10(5) daltons) did not rebind to RBC under the same conditions. These data suggest that IC containing high m.w. DNA bind to and remain bound to RBC more effectively than IC containing lower m.w. DNA, and thus may be more easily cleared from the circulation by the RBC IC clearance mechanism. Thus, the size of the DNA in the IC may be a significant factor in the pathogenicity of DNA/anti-DNA complexes in SLE.

摘要

[3H]双链DNA/抗DNA免疫复合物(IC)形成后,固定补体,并在全血中迅速与红细胞(RBC)结合(不到5分钟),但从细胞中释放的速度较慢。释放速度取决于抗体与DNA的比例以及复合物中DNA的分子量。例如,与高分子量DNA(6×10⁶道尔顿)形成的复合物释放得比与低分子量DNA(2至6×10⁵道尔顿)形成的复合物更慢(t1/2 = 60分钟)(t1/2 = 15至20分钟)。从细胞中作为完整抗原/抗体/补体复合物释放的[3H]双链DNA/抗DNA复合物不会重新结合到RBC上,但会结合到Raji细胞上,并可被抗C3d单克隆抗体沉淀。当这些含有高分子量DNA的释放的IC(RIC)与额外的抗DNA抗体和新鲜补体一起孵育时,它们会重新结合到RBC上。然而,在相同条件下,含有低分子量DNA(5×10⁵道尔顿)的RIC不会重新结合到RBC上。这些数据表明,含有高分子量DNA的IC比含有低分子量DNA的IC更有效地结合并保持与RBC的结合,因此可能更容易通过RBC IC清除机制从循环中清除。因此,IC中DNA的大小可能是SLE中DNA/抗DNA复合物致病性的一个重要因素。

相似文献

1
The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.[3H] -双链DNA/抗DNA免疫复合物形成、红细胞结合及释放至血清中的动力学:DNA分子量及抗体过量条件的影响
J Immunol. 1984 Oct;133(4):2079-84.
2
Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.可溶性补体结合抗体/dsDNA免疫复合物与人红细胞上CR1结合的定量分析。
J Immunol. 1987 Dec 1;139(11):3739-47.
3
In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.抗体/双链DNA免疫复合物与兔和豚鼠血小板结合的体内和体外研究。
J Immunol. 1985 Apr;134(4):2550-8.
4
Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.抗双链DNA抗体的清除:天然免疫复合物清除机制
Arthritis Rheum. 2000 Oct;43(10):2265-75. doi: 10.1002/1529-0131(200010)43:10<2265::AID-ANR14>3.0.CO;2-J.
5
Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.免疫复合物与人类血细胞上补体受体相互作用的动力学:与红细胞相互作用过程中复合物的修饰
Clin Exp Immunol. 1982 Jun;48(3):715-25.
6
Clearance and organ localization of small DNA anti-DNA immune complexes in mice.小鼠中小DNA抗DNA免疫复合物的清除及器官定位
J Immunol. 1988 Mar 15;140(6):1816-22.
7
The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.补体介导的可溶性抗体/双链DNA免疫复合物与人中性粒细胞的结合。
J Immunol. 1983 Jun;130(6):2656-62.
8
BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.在人补体存在的情况下形成的牛血清白蛋白-抗牛血清白蛋白免疫复合物不会与自身红细胞结合。
Immunology. 1988 Jul;64(3):381-4.
9
Clearance kinetics and immunochemistry in rabbits of soluble antibody/DNA immune complexes. Effects of antibody class and DNA conformation.兔体内可溶性抗体/DNA免疫复合物的清除动力学及免疫化学。抗体类别和DNA构象的影响。
J Immunol. 1987 Jul 1;139(1):180-7.
10
The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.人抗体/双链DNA免疫复合物从兔循环中清除的动力学。双链DNA大小、类风湿因子以及抗体的还原和烷基化的影响。
J Immunol. 1986 May 15;136(10):3785-92.

引用本文的文献

1
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.肽基精氨酸脱亚氨酶抑制作用可调节免疫和保护血管在狼疮鼠模型中发挥作用。
J Clin Invest. 2013 Jul;123(7):2981-93. doi: 10.1172/JCI67390. Epub 2013 Jun 3.
2
Complement activation and complement receptors in systemic lupus erythematosus.系统性红斑狼疮中的补体激活与补体受体
Springer Semin Immunopathol. 1986;9(2-3):179-94. doi: 10.1007/BF02099021.
3
Clearance of cryoglobulins in man.人体中冷球蛋白的清除
Springer Semin Immunopathol. 1988;10(1):75-89. doi: 10.1007/BF02054025.
4
Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.免疫复合物与红细胞CR1(1型补体受体):CR1数量对结合和释放反应的影响。
Clin Exp Immunol. 1988 Mar;71(3):481-5.
5
Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.破伤风类毒素-抗破伤风类毒素复合物:一种研究人类免疫复合物补体转运系统的潜在模型。
Clin Exp Immunol. 1987 Aug;69(2):468-76.
6
The aetiology and pathogenesis of major systemic vasculitides.主要系统性血管炎的病因及发病机制。
Postgrad Med J. 1986 Jul;62(729):627-36. doi: 10.1136/pgmj.62.729.627.
7
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody.用抗Fcγ受体单克隆抗体阻断免疫复合物的清除。
J Exp Med. 1986 Aug 1;164(2):474-89. doi: 10.1084/jem.164.2.474.
8
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.黑猩猩体内可溶性补体结合抗体/双链DNA免疫复合物的处理
J Clin Invest. 1989 Sep;84(3):962-70. doi: 10.1172/JCI114259.
9
Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.使用异源多聚体单克隆抗体将抗原附着于人红细胞的C3b受体:一种潜在的治疗方法。
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3305-9. doi: 10.1073/pnas.88.8.3305.